TABLE 2.
MICs for the clinical isolates of ESBL-producing P. mirabilis and P. stuartii
| Strain (beta-lactamase) | MIC (μg/ml)a
|
|||||||
|---|---|---|---|---|---|---|---|---|
| ATM | FOX | CTX | CTX + CLA | CAZ | FEP | CPO | MOX | |
| P. mirabilis CF529 (TEM-92) | 0.5 | 8 | 64 | 0.12 | 8 | 32 | 16 | 0.25 |
| P. stuartii 1606 (TEM-92) | 2 | 2 | 32 | ≤0.06 | 8 | 2 | 2 | 0.25 |
| P. mirabilis CF 39 (TEM-3) | 0.06 | 4 | 2 | 0.06 | 0.5 | 0.25 | 2 | 0.25 |
| P. mirabilis CF 669 (TEM-66) | 0.25 | 8 | 8 | 0.06 | 8 | 0.12 | 16 | 0.25 |
a
ATM, aztreonam; FOX, cefoxitin; CTX, cefotaxime; CLA, clavulanic acid (2 μg/ml); CAZ, ceftazidime, FEP, cefepime; CPO, cefpirome; MOX, moxalactam.